Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daiken Biomedical CoTPE:7780 +0.92%30 12-1 Month Momentum % is -27.86% as of Sep. 22, 2026. GuruFocus rates TPE:7780 with a GF Score™ of 30/100. The stock has 4 warning signs investors should review. Among 2,034 Consumer Packaged Goods companies, Daiken Biomedical Co ranks worse than 78.42% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-22), Daiken Biomedical Co's 12-1 Month Momentum % is -27.86%.
The industry rank for Daiken Biomedical Co's 12-1 Month Momentum % or its related term are showing as below:
TPE:7780's 12-1 Month Momentum % is ranked worse than 78.42% of 2034
companies
in the Consumer Packaged Goods industry
Industry Median: -7.605
vs TPE:7780: -27.86
Daiken Biomedical Co (TPE:7780) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Daiken Biomedical Co 12-1 Month Momentum % Related Terms
TPE:7780 vs KHC, GIS: 12-1 Month Momentum % Comparison
For the Packaged Foods subindustry, Daiken Biomedical Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiken Biomedical Co 12-1 Month Momentum % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Daiken Biomedical Co's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Daiken Biomedical Co's 12-1 Month Momentum % falls into.
Daiken Biomedical Co (TPE:7780) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -27.86% mean?
Daiken Biomedical Co (TPE:7780) has a 12-1 Month Momentum % of -27.86% as of Sep. 22, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Daiken Biomedical Co and its competitors. According to the industry distribution chart, Daiken Biomedical Co ranks #1595 out of 2034 companies in the Consumer Packaged Goods industry, placing it in the top 78.4%.
Is Daiken Biomedical Co's 12-1 Month Momentum % too high?
Daiken Biomedical Co's current 12-1 Month Momentum % is -27.86%. Based on the distribution chart, Daiken Biomedical Co ranks #1595 out of 2034 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Daiken Biomedical Co has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's 12-1 Month Momentum % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Daiken Biomedical Co ranks #1595 out of 2034 companies for 12-1 Month Momentum %. This places Daiken Biomedical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Consumer Packaged Goods company?
A good 12-1 Month Momentum % depends on the Consumer Packaged Goods industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Daiken Biomedical Co and its competitors. Daiken Biomedical Co's current 12-1 Month Momentum % is -27.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current 12-1 Month Momentum % of -27.86%. The current 12-1 Month Momentum % is -27.86%. Daiken Biomedical Co's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current 12-1 Month Momentum % is -27.86% as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
30GF Score
Get the complete analysis for TPE:7780
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:7780 has been successfully added to your 
